Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 0.713. It has been cited 115 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.713
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural Research Program of NIH
Grant: Z01 BC010891
Intramural Research Program of NIH
Grant: ZIA BC010891
National Natural Science Foundation of China
Grant: No. 81972284
National Natural Science Foundation of China
Grant: No. 81773260
National Natural Science Foundation Youth Project of Jiangsu, China
Grant: No. BK20171047
National Institutes of Health
Grant: 1Z01BC010891-01
Antibody Therapy of Cancer
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Additional file 1 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Additional file 2 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Additional file 2 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Additional file 3 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Additional file 3 of Tyrosine kinase signaling-independent MET-targeting with CAR-T cells